• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Philips, Steris to hire in Ohio

Philips, Steris to hire in Ohio

December 20, 2011 By MassDevice staff

Philips Healthcare (NYSE:PHG) said it plans to move 100 jobs to a Highland Heights, Ohio-based research & development facility as it cuts back at its nuclear medicine arm in San Jose, Calif.

The Dutch subsidiary in 2006 moved its nuclear medicine HQ from California to the Ohio location, where the company currently employs 1,200.

The proposed additions, with average annual salaries of $115,000, will be a part of Philips’ medical imaging R&D operation, according to Cleveland.com.

Sign up to get our free newsletters delivered straight to your inbox

Philips sought government help for the move. The technology titan wanted at least $10 million in assistance from the Ohio government; the Ohio Third Frontier Commission came up with half that in a grant. Ohio Gov. John Kasich (R) is expected to reveal his own benison today, according to the website, in the form of a tax credit. Another $3 million could come via an interest-free loan from Cuyahoga County and the Global Cardiovascular Innovation Center put up a 3-year, $500,000 grant based on job-creation milestones, according to Cleveland.com.

For its part, Mentor, Ohio-based Steris said it’s planning “a significant investment involving a number of jobs” there, a spokesman told the website.

Job creation has been a scarce thing in the medical device world lately.

Stryker (NYSE:SYK) recently made good on a promise to cut jobs ahead of the 2.3% med-tech tax by shuttering two New York plants, leaving 160 out of work.

British orthopedic giant Smith & Nephew (NYSE:SNN) completed a round of recent layoffs, including 24 cuts in Massachusetts. SNN also terminated 80 positions in Tennessee.

Earlier this year, Philips Healthcare parent Royal Philips Electronics announced plans to cut 4,500 jobs to boost profits after reporting its worst quarterly results in two years.

The Dutch conglomerate posted profits of $105.3 million (€76 million) on sales of $7.48 billion (€5.40 billion) for the third quarter, down 85.5 percent and 1.2 percent, respectively.

Philips’ healthcare division logged "solid" growth of 7 percent after taking account of exchange rates, according to a press release. Philips Healthcare reported sales of $2.85 billion (€2.08 billion) during the third quarter, compared with sales of $2.84 billion (€2.07 billion) during Q3 2010.

Filed Under: News Well, Research & Development Tagged With: Layoffs, Philips, Smith & Nephew, Stryker

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy